Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046124
Filing Date
2025-03-27
Accepted
2025-03-27 16:29:29
Documents
86
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tyra-20241231.htm   iXBRL 10-K 2901966
2 EX-19.1 tyra-ex19_1.htm EX-19.1 68021
3 EX-23.1 tyra-ex23_1.htm EX-23.1 6831
4 EX-31.1 tyra-ex31_1.htm EX-31.1 16843
5 EX-31.2 tyra-ex31_2.htm EX-31.2 17043
6 EX-32.1 tyra-ex32_1.htm EX-32.1 9046
7 EX-32.2 tyra-ex32_2.htm EX-32.2 9009
8 GRAPHIC img24449912_0.jpg GRAPHIC 211075
9 GRAPHIC img24449912_1.jpg GRAPHIC 238987
10 GRAPHIC img24449912_2.jpg GRAPHIC 172603
11 GRAPHIC img24449912_3.jpg GRAPHIC 170793
12 GRAPHIC img24449912_4.jpg GRAPHIC 180945
13 GRAPHIC img24449912_5.jpg GRAPHIC 247018
14 GRAPHIC img24449912_6.jpg GRAPHIC 207188
  Complete submission text file 0000950170-25-046124.txt   14273668

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20241231.xsd EX-101.SCH 1274586
89 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20241231_htm.xml XML 1904715
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40800 | Film No.: 25779789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)